SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-071939
Filing Date
2022-06-16
Accepted
2022-06-16 16:30:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2218595d1_defa14a.htm DEFA14A 15894
  Complete submission text file 0001104659-22-071939.txt   17103
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33357 | Film No.: 221020997
SIC: 2836 Biological Products, (No Diagnostic Substances)